Covering: up to 2008 This comprehensive review describes the current status and
knowledge of biochemical and molecular processes involved in allyl/propenyl phenol …

Human papillomavirus is responsible for common condyloma acuminata and a number of
premalignant and malignant anogenital lesions. The immunocompromised population is at …

Background Anogenital warts (AGW) can cause economic burden on healthcare systems
and are associated with emotional, psychological and physical issues. Objective To provide …

Antibiotic-resistant bacteria, which are growing at a frightening rate worldwide, has put the
world on a long-standing alert. The COVID-19 health crisis reinforced the pressing need to …

Background Interferon has been widely used in the treatment of genital warts for its
immunomodulatory, antiproliferative and antiviral properties. Currently, no evidence that …

Background: We examined a range of common bacterial and viral sexually transmitted
infections as risk factors for HIV seroconversion in a community-based cohort of HIV …

Abstract Background External anogenital warts (EGWs) are non‐malignant skin tumours
caused by human papillomavirus. They are one of the fastest growing sexually transmitted …

Background We assessed the cost-effectiveness of adding a quadrivalent (6/11/16/18)
human papillomavirus (HPV) vaccine to the current screening programme in the UK …

Background Information on the health-related quality of life (HRQoL) of patients with genital
warts (GW) in populations in mainland China is still limited. The aim of the study was to use …

The family of human papilloma viruses (HPV) comprises more than 100 genotypes.
Approximately 30 of the genotypes are responsible for infections in the human anogenital …